{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:40:04Z","timestamp":1749494404544,"version":"3.41.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00520-025-09597-1","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:13:45Z","timestamp":1748906025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["At-home 1-week hydration improves tolerance and treatment intensity of high-dose cisplatin in locally advanced head and neck cancer: a retrospective study"],"prefix":"10.1007","volume":"33","author":[{"given":"Camelia","family":"Billard-Sandu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea","family":"Cabulca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Rassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Akla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Zeghondy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Gan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Scotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Puglissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Di Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Breuskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Temam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"3","key":"9597_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M et al (2020) Observatoire mondial du cancer\u202f: \u00ab\u202fCancer Today\u202f\u00bb. Lyon\u202f: Centre international de recherche sur le cancer.\u00a0https:\/\/gco.iarc.fr\/today,consult\u00e9enmars2022","key":"9597_CR2"},{"doi-asserted-by":"crossref","unstructured":"Winn DM, Lee YCA, Hashibe M, Boffetta P (2015) INHANCE consortium. The INHANCE consortium: toward a better understanding of the causes and mechanisms of head and neck cancer. Oral Dis 21(6)\u00a0:685\u201393","key":"9597_CR3","DOI":"10.1111\/odi.12342"},{"issue":"1","key":"9597_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primers 6(1):92","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"9597_CR5","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","volume":"31","author":"JP Machiels","year":"2020","unstructured":"Machiels JP, Ren\u00e9 Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V et al (2020) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(11):1462\u20131475","journal-title":"Ann Oncol"},{"issue":"80","key":"9597_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.oraloncology.2018.03.001","volume":"1","author":"O Iocca","year":"2018","unstructured":"Iocca O, Farcomeni A, Di Rocco A, Di Maio P, Golusinski P, Pardi\u00f1asL\u00f3pez S et al (2018) Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options. Oral Oncol 1(80):40\u201351","journal-title":"Oral Oncol"},{"unstructured":"NCCN (2023) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf","key":"9597_CR7"},{"issue":"11","key":"9597_CR8","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2(11):2490\u20132518","journal-title":"Toxins (Basel)"},{"key":"9597_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106579","volume":"146","author":"S Cavalieri","year":"2023","unstructured":"Cavalieri S, Platini F, Barretta F, Nuzzolese I, Ottini A, Bergamini C et al (2023) Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience. Oral Oncol 146:106579","journal-title":"Oral Oncol"},{"issue":"11","key":"9597_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142225","volume":"10","author":"ZY Bhat","year":"2015","unstructured":"Bhat ZY, Cadnapaphornchai P, Ginsburg K, Sivagnanam M, Chopra S, Treadway CK et al (2015) Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study. PLoS ONE 10(11):e0142225","journal-title":"PLoS ONE"},{"key":"9597_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.106130","volume":"134","author":"T Gupta","year":"2022","unstructured":"Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2022) Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior? Oral Oncol 134:106130","journal-title":"Oral Oncol"},{"issue":"11","key":"9597_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.21037\/atm.2018.05.10","volume":"6","author":"X Le","year":"2018","unstructured":"Le X, Hanna EY (2018) Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. Ann Transl Med 6(11):229","journal-title":"Ann Transl Med"},{"doi-asserted-by":"crossref","unstructured":"Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T et al (2022) Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II\/III Randomized Controlled Trial. JCO. JCO 21:01293","key":"9597_CR13","DOI":"10.1200\/JCO.21.01293"},{"issue":"2","key":"9597_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","volume":"334","author":"X Yao","year":"2007","unstructured":"Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334(2):115\u2013124","journal-title":"Am J Med Sci"},{"issue":"1","key":"9597_CR15","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1186\/s12885-019-6233-9","volume":"19","author":"MJDL van der Vorst","year":"2019","unstructured":"van der Vorst MJDL, Neefjes ECW, Toffoli EC, Oosterling-Jansen JEW, Vergeer MR, Leemans CR et al (2019) Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin. BMC Cancer 19(1):1066","journal-title":"BMC Cancer"},{"unstructured":"US Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE). version 4.0. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010\u201306-14_QuickReference_5x7.pdf","key":"9597_CR16"},{"doi-asserted-by":"crossref","unstructured":"Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V et al (2019) Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer. Front Oncol 9:86.","key":"9597_CR17","DOI":"10.3389\/fonc.2019.00086"},{"issue":"2","key":"9597_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5049\/EBP.2014.12.2.55","volume":"12","author":"GS Oh","year":"2014","unstructured":"Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A et al (2014) Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies. Electrolyte Blood Press 12(2):55\u201365","journal-title":"Electrolyte Blood Press"},{"issue":"9","key":"9597_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73(9):994\u20131007","journal-title":"Kidney Int"},{"key":"9597_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.oraloncology.2016.06.004","volume":"59","author":"D Rades","year":"2016","unstructured":"Rades D, Seidl D, Janssen S, Bajrovic A, Hakim SG, Wollenberg B et al (2016) Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg\/m(2) cisplatin on five days every four weeks an alternative to 100mg\/m(2) cisplatin every three weeks? Oral Oncol 59:67\u201372","journal-title":"Oral Oncol"},{"issue":"2","key":"9597_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.21873\/anticanres.16220","volume":"43","author":"I Zwaan","year":"2023","unstructured":"Zwaan I, Soror T, Bruchhage KL, Hakim SG, Schild SE, Rades D (2023) Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck. Anticancer Res 43(2):795\u2013800","journal-title":"Anticancer Res"},{"issue":"15","key":"9597_CR22","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1088\/0031-9155\/51\/15\/002","volume":"51","author":"L Marcu","year":"2006","unstructured":"Marcu L, Bezak E, Olver I (2006) Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Phys Med Biol 51(15):3625\u20133637","journal-title":"Phys Med Biol"},{"issue":"1","key":"9597_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1425","volume":"5","author":"A Ameri","year":"2022","unstructured":"Ameri A, Norouzi S, Sourati A, Azghandi S, Novin K, Taghizadeh-Hesary F (2022) Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer. Cancer Rep (Hoboken) 5(1):e1425","journal-title":"Cancer Rep (Hoboken)"},{"key":"9597_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103345","volume":"162","author":"F De Felice","year":"2021","unstructured":"De Felice F, Belgioia L, Alterio D, Bonomo P, Maddalo M, Paiar F et al (2021) Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Crit Rev Oncol Hematol 162:103345","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"9597_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1200\/JCO.2017.74.9457","volume":"36","author":"V Noronha","year":"2018","unstructured":"Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A et al (2018) Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial. J Clin Oncol 36(11):1064\u20131072","journal-title":"J Clin Oncol"},{"doi-asserted-by":"publisher","unstructured":"Sharma A, Kumar M, Bhasker S, Thakar A, Pramanik R, Biswas A et al (2022) An open-label, noninferiority phase III RCT of weekly versus three weekly cisplatin and radical radiotherapy in locally advanced head and neck squamous cell carcinoma (ConCERT trial). J Clin Oncol [Internet]. [cited 2025 May 9]; Available from:https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.6004","key":"9597_CR26","DOI":"10.1200\/JCO.2022.40.16_suppl.6004"},{"issue":"18","key":"9597_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70235","volume":"13","author":"Y Imamura","year":"2024","unstructured":"Imamura Y, Kiyota N, Tahara M, Kodaira T, Hayashi R, Nishino H et al (2024) Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II\/III trial of JCOG1008. Cancer Med 13(18):e70235","journal-title":"Cancer Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09597-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:03:31Z","timestamp":1749492211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09597-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9597"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09597-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"530"}}